NCM
AZN icon

Next Capital Management’s AstraZeneca AZN Stock Holding History

Next Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-253
Closed -$21K – 304
2019
Q2 		$21K Buy
+253
New +$19.8K 0.01% 282

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Next Capital Management's AZN Position: Q3 2019 in Review

Next Capital Management sold out of AstraZeneca (AZN) in Q3 2019, closing a stake of 253 shares — an estimated $21K sold.

Next Capital Management first reported a position in AZN in Q2 2019 and held it in 1 quarter. The position peaked at $21K in Q2 2019. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

  • Next Capital Management reported no remaining AstraZeneca position as of Q3 2019 after selling out during the quarter.
  • Next Capital Management sold 253 AstraZeneca shares in Q3 2019, an estimated $21K.
  • Next Capital Management first reported a position in AstraZeneca in Q2 2019 and held it in 1 quarter.
  • Next Capital Management's AstraZeneca position peaked at $21K in Q2 2019.
  • 555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.